Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10392386
JAK inhibitors containing a 4-membered heterocyclic amide
granted -
US 10391097
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
granted -
US 10391095
DNA-PK inhibitors
granted -
US 10391175
BET bromodomain inhibitors and therapeutic methods using the same
granted -
US 10385080
STAT6 inhibitors
granted -
US 10385031
Substituted piperazines as selective HDAC1,2 inhibitors
granted -
US 10376510
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
granted -
US 10377772
Macrocyclic LRRK2 kinase inhibitors
granted -
US 10376515
Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG7
granted -
US 10370367
IRAK inhibitors and method for making and using
granted -
US 10370371
Substituted pyrimidine Bmi-1 inhibitors
granted -
US 10370360
Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
granted -
US 10370333
Sulfonamide compounds and uses as TNAP inhibitors
granted -
EP 3515433
DIE BLUT-HIRN-SCHRANKE PASSIERENDE DOPAMIN-B-HYDROXYLASE-INHIBITOREN
granted -
US 10363261
Enolase inhibitors and methods of treatment therewith
granted -
US 10364238
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
granted -
US 10364258
Heteroaryl inhibitors of PDE4
granted -
US 10358421
Piperidine derivatives as HDAC1/2 inhibitors
granted -
US 10351532
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted -
US 10344025
GLS1 inhibitors for treating disease
granted -
US 10344033
2-aminoquinazoline derivatives as P70S6 kinase inhibitors
granted -
US 10342786
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10342764
Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
granted -
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted